The clinical significance of titered antinuclear antibodies.
D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D001171:Arthritis, Juvenile / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000276:immunology*; D001323:Autoantibodies / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D005455:Fluorescent Antibody Technique; D006801:Humans; D007223:Infant; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D011565:Psoriasis / Q000150:complications; D012595:Scleroderma, Systemic / Q000276:immunology*; D013167:Spondylitis, Ankylosing / Q000276:immunology*
D000974:Antibodies, Antinuclear; D001323:Autoantibodies